Amphastar Pharma (AMPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 170,412 | 151,844 | 144,531 | 156,333 | 126,588 |
| Marketable Securities | 114,835 | 72,236 | 114,710 | 21,864 | 12,520 |
| Receivables | 160,727 | 138,036 | 115,469 | 88,975 | 78,930 |
| Inventories | 176,890 | 153,741 | 105,833 | 103,584 | 92,807 |
| TOTAL | $636,016 | $534,071 | $489,600 | $378,319 | $318,119 |
| Non-Current Assets | |||||
| PPE Net | 310,567 | 297,345 | 282,746 | 238,266 | 244,244 |
| Investments And Advances | 0 | 10,996 | 15,212 | 2,414 | 3,985 |
| Other Non-Current Assets | 682,716 | 735,058 | 725,354 | 122,988 | 105,181 |
| TOTAL | $993,283 | $1,043,399 | $1,023,312 | $363,668 | $353,410 |
| Total Assets | $1,629,299 | $1,577,470 | $1,512,912 | $741,987 | $671,529 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,641 | 234 | 436 | 3,046 | 2,202 |
| Accounts payable and accrued liabilities | 148,348 | 157,057 | 93,366 | 84,242 | 89,545 |
| Accrued Expenses | N/A | N/A | 126,090 | N/A | N/A |
| TOTAL | $158,156 | $173,759 | $225,407 | $94,862 | $103,810 |
| Non-Current Liabilities | |||||
| Long Term Debt | 608,749 | 601,630 | 589,579 | 72,839 | 74,776 |
| Other Non-Current Liabilities | 73,589 | 69,783 | 58,505 | 45,484 | 45,702 |
| TOTAL | $682,338 | $671,413 | $648,084 | $118,467 | $122,197 |
| Total Liabilities | $840,494 | $845,172 | $873,491 | $213,329 | $226,007 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 45,370 | 47,650 | 48,096 | 47,897 | 48,147 |
| Common Shares | 6 | 6 | 6 | 6 | 6 |
| Retained earnings | 666,881 | 568,787 | 409,268 | 271,723 | 180,337 |
| Other shareholders' equity | -5,462 | -8,895 | -8,909 | -8,148 | -7,244 |
| TOTAL | $788,805 | $732,298 | $639,421 | $528,658 | $445,522 |
| Total Liabilities And Equity | $1,629,299 | $1,577,470 | $1,512,912 | $741,987 | $671,529 |